Clinical Trials Browser

Active not recruiting × Lymphatic Metastasis × 30 days × Clear all

NCT03793166 2026-03-18

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Lymphatic Metastasis

NCT05970913 2026-03-09

PET-CT Predicting Lymph Nodes Metastasis

Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis